Clinical evaluation of determinants of glycemic control. A new approach using serum glucose, C-peptide, and body mass indexes in type II diabetic patients.

  • Kuame Osei
  • Published 1986 in Archives of internal medicine


We evaluated the clinical characteristics and relationships between values of serum glucose, C-peptide, and body mass index (BMI) in 40 type II diabetic patients. Patients were divided into three groups according to the drug therapy: group A (n=16), oral sulfonylurea agent; group B (n=16), insulin alone; and group C (n=8), combined insulin and oral agent… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.